Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
Abstract
Analysis of[¹²⁵I]. interferon gamma cross-linked to its receptor on various human cells by SDS-PAGE revealed that there are at least three different types of human interferon gamma receptors. In WISH, HeLa, FS11 and other tissue cells an Mr 90,000-105,000 receptor was found. In monocytes and in the myeloid cell line KG-1 an Mr 140,000 receptor was found while in Daudi lymphoblastoid cells an Mr 95,000-115,000 receptor was found. The various receptors were isolated from these cells by extraction followed by affinity chromotography on an immobilized interferon gamma column. The resulting purified preparations retained their original affinity for interferon gamma and were used for immunizing mice and subsequent development of highly specific antibodies.

Term
Term ended
Projected expiry passed 6 April 2007, 19.5 years ago.
- Priority
- Filed
- Published
- Projected expiry
- Today
1 sheet
Sheet 1
Every citation, both waysCites: the store holds 0 of 1
| Reference | Relation | Cited during |
|---|---|---|
| PROC. NATL. ACAD. SCI. USA, vol. 81, August 1984, pages 5160-5164, Washington D.C., US; F.H. SARKAR et al.: "Receptors for human gamma interferon: binding and crosslinking of 125I-labeled recombinant human gamma interferon to receptors on WISH cells" | Non-patent | Search report |
| UCLA SYMP. MOLL. CELL. BIOL., NEW SERIES, vol. 50, 1986, pages 269-278, Alan R. Liss Inc.; M. RUBINSTEIN et al.: "Multiple interferon-gamma receptors" | Non-patent | Search report |
| THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 260, no. 2, 25th January 1985, pages 1191-1195, The Amrican Society of Biological Chemists, Inc., US; S.J. LITTMAN: "Binding of human recombinant 125I-interferon gamma to receptors on human cells" | Non-patent | Search report |
| THE JOURNAL OF IMMUNOLOGY, vol. 136, no. 1, 1st January 1986, pages 169-173, The American Association of Immunologists, US; P. ORCHANSKY et al.: "The interferon-gamma receptor in human monocytes is different from the one in nonhematopoietic cells" | Non-patent | Search report |
| S. FERRONE et al.: "Handbook of monoclonal antibodies", 1985, chapter 8, Noyes Publictions, Park Ridge, New York, US; M. SCHMITT et al.: "Monoclonal antibodies as tools to study receptor-transducer-effector systems" | Non-patent | Search report |
| CHEMICAL ABSTRACTS, vol. 107, no. 11, 14th September 1987, page 545, abstract no. 94974y, Columbus, Ohio, US; D. NOVICK: "Purification and characterization of the receptor for human interferon-gamma", & BIOL. INTERFERON SYST., PROC. ISIR-TNO MEET. INTERFERON SYST. 1986 (Pub. 1987), 121-8 (7th - 12th September 1986, Espoo, Finland) | Non-patent | Search report |
19 members in 9 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 78444 | Israel | – | |
| 7844486 | Israel | A | |
| 7844486 | Israel | A | |
| 78444 | – | – | – |
| IL19860078444 | – | – | – |
Members19
| Document | Office | Kind | |
|---|---|---|---|
| IL78444A0 | Israel | A0 | |
| IL78444D0 | Israel | D0 | |
| EP0240975A2 | European Patent Office (EPO) | A2 | |
| AU7095887A | Australia | A | |
| ZA872523B | South Africa | B | |
| JPS6317699A | Japan | A | |
| DE240975T1 | Germany | T1 | |
| EP0240975A3This record | European Patent Office (EPO) | A3 | |
| US4897264A | United States of America | A | |
| AU614487B2 | Australia | B2 | |
| IL78444A | Israel | A | |
| CA1323728C | Canada | C | |
| EP0240975B1 | European Patent Office (EPO) | B1 | |
| DE3750342D1 | Germany | D1 | |
| DE3750342T2 | Germany | T2 | |
| ES2061448T3 | Spain | T3 | |
| JPH0770199A | Japan | A | |
| JPH0787795B2 | Japan | B2 | |
| JP2577868B2 | Japan | B2 |
45 legal events, as 5 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Be: patent expiredExpiredBE20 | BE20 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Se: european patent has lapsedLapsedEUG | EUG | EP | |
| Nl: ceased due to reaching the maximum lifetime of a patentCeasedNLV7 | NLV7 | EP | |
| Patent ceasedCeasedPL | PL | CH | |
| Patent expired after termination of 20 yearsExpiredPE20 | PE20 | GB | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| European patent in force as of 2002-01-01IF02 | IF02 | GB | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Se: european patent in force in swedenEAL | EAL | EP | |
| Validation in greece3013918FG4A | FG4A | GR | |
| Definitive protectionFG2A | FG2A | ES | |
| It: translation for a ep patent filedITF | ITF | EP | |
| It: translation for a ep patent filedITF | ITF | EP | |
| Corresponds to:REF | REF | EP | |
| Fr: translation filedET | ET | EP | |
| Designated contracting statesAK | AK | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Search report despatchedORIGINAL CODE: 0009013PUAL | PUAL | EP | |
| De: translation of patent claimsDET | DET | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | EP | |
| Fr: translation of claims filedEL | EL | EP | |
| It: translation for ep claims filedITCL | ITCL | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0240975
- Publication, DOCDB
- 0240975
- Publication, EPODOC
- EP0240975
- Application
- 87105078
- Application, DOCDB
- 87105078
- Application, EPODOC
- EP19870105078
Titles3
- German
- Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen
- English
- Human gamma interferon-specific receptor protein, antibody against said protein, methods for obtaining said protein and said antibody and compositions containing said protein and antibody
- French
- Protéine réceptrice spécifique de l'interféron gamma humain, anticorps contre cette protéine, méthodes pour obtenir cette protéine et cet anticorps et compositions contenant cette protéine et cet anticorps
Classification
- CPC, 5
- C07K16/2866
- A61K38/00
- A61K39/395
- C07K14/715
- A61P43/00
- IPC, 22
- A61K38 00
- A61K38 21
- A61K39 395
- A61P43 00
- C07K1 16
- C07K1 22
- C07K14 005
- C07K14 195
- C07K14 435
- C07K14 52
- C07K14 555
- C07K14 57
- C07K14 705
- C07K14 715
- C07K16 00
- C07K16 28
- C12N5 00
- C12N5 10
- C12P21 00
- C12P21 08
- C12R1 91
- G01N33 53
Designated states1
- Contracting states, 1
- Sweden